Case Report
 
Meningococcal serogroup W and varicella-zoster virus meningitis in an Irish infant
Kene Maduemem1, Adela Vatca1, Ahmed Satti Mohammed2, Yurelis Diaz Rodriguez1
1Registrar, Pediatrics, Cork University Hospital, Cork, Ireland
2Registrar, Pediatrics, Mercy University Hospital, Cork, Ireland

Article ID: Z01201801CR10878MK
doi:10.5348/ijcri-201809-CR-10878

Corresponding Author:
Kene Ebuka Maduemem,
Department of Paediatrics,
University Hospital Galway,
Galway, Ireland,
H91 YR71

Access full text article on other devices

  Access PDF of article on other devices

[Abstract HTML]   [Full Text HTML]   [Full Text PDF]   [Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar]


How to cite this article
Maduemem K, Vatca A, Mohammed AS, Rodriguez YD. Meningococcal serogroup W and varicella-zoster virus meningitis in an Irish infant. Int J Case Rep Images 2018;9(1):56–59.


ABSTRACT

Introduction: Meningococcal disease remains a major cause of morbidity and mortality in children globally. The most common serogroups in Europe are B and C. There has been a downward trend in the incidence of the latter because of the immunization schedules in most European countries. N. meningitidis W135, otherwise referred to as MenW is an uncommon serogroup but gained popularity following the Hajj outbreaks in the year 2000.
Case Report: A previously well 11-month-old girl presented with varicella rash, high grade pyrexia. She became very irritable with bulging anterior fontanelle. Examination findings revealed nuchal rigidity. MenW and varicella zoster virus were isolated in cerebrospinal fluid (CSF). She received a three-week course of intravenous ceftriaxone and acyclovir. Magnetic resonance imaging scan of the brain showed some empyema collection in the right frontal lobe. She had some motor regression. She recovered but with residual sensorineural hearing loss.
Conclusion: This case might represent an emerging trend of this rather uncommon serogroup. This has been anticipated by some European countries where MenACWY vaccine has been incorporated in their immunization schedules.

Keywords: MenACWY vaccine, Meningococcal meningitis, MenW serogroup, Varicella-zoster virus


[Abstract HTML]   [Full Text HTML]   [Full Text PDF]

Author Contributions
Kene Ebuka Maduemem – Substantial contributions to conception and design, Acquisition of data, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Adela Vatca – Substantial contributions to conception and design, Acquisition of data, Acquisition of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Ahmed Satti Mohammed – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Yurelis Diaz Rodriguez – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Guarantor of Submission
The corresponding author is the guarantor of submission.
Source of Support
None
Conflict of Interest
Authors declare no conflict of interest.
Copyright
© 2018 Kene Maduemem et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.